Fatty Acid Esters May Ease Osteoarthritis Pain
ORLANDO, Fla.--At the Experimental Biology 2001 conference (www.faseb.org) April 1, Robert Hesslink presented a poster on how fatty acid esters may benefit osteoarthritis. In a double-blind, placebo-controlled trial, 100 volunteers, ages 37 to 77 with chronic osteoarthritis, consumed 500 mg of a blend of fatty acid esters. Questionnaires that asked questions about pain and mobility were then given to patients. Patients reported significant improvements in walking on level ground and stairs, which they continued to experience 60 days after supplementation had stopped. The study was sponsored by San Diego-based Imagenetix, which also provided the product, Celadrin.